Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c770da2ecaed65d358f18fdaec32add http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89847eb45584205c9cdc3856fbcb8b31 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-248 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2004-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e10cc3e4d930febf39d42476699cfb17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de9ed306619eef28e3ef093f20ad4bc3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6f57f0352c3928f217c207edf23b5ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f25799ee0797a361d1dfd2c78511a58 |
publicationDate |
2009-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2358761-C2 |
titleOfInvention |
Therapeutic agent in spinal marrow injury containing interleukine-6 antagonist |
abstract |
FIELD: medicine. n SUBSTANCE: invention refers to medicine and concerns a therapeutic agent applied in spinal marrow injury containing interleukine-6 antagonist. The therapeutic agent in spinal marrow injury contains IL-6 receptor antibody as an active ingredient. n EFFECT: composition is applicable for spinal marrow injury treatment. n 27 cl, 4 ex, 5 dwg |
priorityDate |
2003-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |